menu
    • menu

    Company profile for Towa Pharmaceutical

    Towa Pharmaceutical-PSE
    News
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    FY2024 Supplementary Material of Financial Results 1Q

    08 Aug 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Towa Pharmaceutical

    Contact Supplier

    Website

    Antibody Engineering

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/prL_A0I4ZVQ

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

    Related CompaniesRelated Companies

    About

    Towa being a pharmaceutical company specialized in generic drugs, has been dedicated to research and development, production, and marketing of generic drugs for many years. Generic drugs have increasingly played a very important role in this aged society, because they are economically affordable for patients and help to curtail the financial burden of the government. In addition to promoting stable supply, quality assurance, and information provision about generic drugs, Towa focuses on research and development of value-added formulations that are easily taken by patients and handled by medical professionals.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Towa Pharmaceuticaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    2-11, Shinbashi-cho, Kadoma, Osaka 571-8580
    Telephone
    Telephone
    +81 0669009100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.towayakuhin.co.jp/english/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/towapharmaceutical/
    youtube
    YouTube
    https://www.youtube.com/@towainternational
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/towa-pharmaceutical-party-content-2847.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of October 23, 2024
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2024-21885.pdf

    FDA
    23 Oct 2024
    Share Share
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    FY2024 Supplementary Material of Financial Results 1Q
    FY2024 Supplementary Material of Financial Results 1Q

    08 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/slide69a.pdf

    PRESS RELEASE
    08 Aug 2024
    Share Share
    Notice of Financial Results of Parent Company, etc.
    Notice of Financial Results of Parent Company, etc.

    25 Jun 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240625_4.pdf

    PRESS RELEASE
    25 Jun 2024
    Share Share
    NHI Drug Price List Updated With Three Ingredients & 7 Generics
    NHI Drug Price List Updated With Three Ingredients & 7 Generics

    13 Jun 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240613.pdf

    PRESS RELEASE
    13 Jun 2024
    Share Share
    Summary of Consolidated Financial Results for the Year Ended March 31, 2024
    Summary of Consolidated Financial Results for the Year Ended March 31, 2024

    14 May 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/assets/result68d.pdf

    PRESS RELEASE
    14 May 2024
    Share Share

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search